Butterfly Medical Ltd.
Developer of an implantable, minimally invasive device intended to treat benign prostatic hyperplasia (BPH). The device is described as non-surgical, reversible, suitable for outpatient settings and local anesthesia, and has received CE marking for Europe. The device is investigational in the United States.
Industries
N/A
Products
Implantable device for treatment of benign prostatic hyperplasia (BPH)
An implantable device intended to retract prostatic tissue to relieve urinary obstruction caused by BPH without cutting, burning, or puncturing tissue.
Implantable device for treatment of benign prostatic hyperplasia (BPH)
An implantable device intended to retract prostatic tissue to relieve urinary obstruction caused by BPH without cutting, burning, or puncturing tissue.
Services
Sponsorship and conduct of investigational device clinical studies
Sponsoring and running clinical evaluations of an implantable BPH device under investigational status.
Clinical evidence generation and early-stage device evaluation
Conduct of early clinical evaluations to demonstrate safety and performance of the implantable device.
Sponsorship and conduct of investigational device clinical studies
Sponsoring and running clinical evaluations of an implantable BPH device under investigational status.
Clinical evidence generation and early-stage device evaluation
Conduct of early clinical evaluations to demonstrate safety and performance of the implantable device.
Expertise Areas
- Implantable device development
- Minimally invasive urology interventions
- Clinical trial design and execution (urology)
- Regulatory strategy and CE marking
Key Technologies
- Implantable medical device engineering
- Minimally invasive procedure design
- Reversible implant mechanisms
- Outpatient procedural workflows